BioPorto A/S
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioPorto A/S
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.
/ 
Frequently asked questions
To buy BioPorto A/S stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioPorto A/S by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioPorto A/S is BIOPOR:xcse. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioPorto A/S has its primary listing on NASDAQ OMX Copenhagen. You can trade BioPorto A/S with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioPorto A/S is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BioPorto A/S as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BioPorto A/S.